Autopsy report · NCT01856582
CD34+ Stem Cell Infusion to Augment Graft Function
Cause of deathRegulatory or ethics
“CliniMACS CD34 Reagent System was FDA approved for clinical use; therefore, patients were treated clinically.”
Life of this trial
- Registered 2 years 7 months after it had already started.
- Ran for about 7 years 10 months before it stopped.
- 23 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Sponsor type
- University, hospital or other
- Conditions
- Waning Donor Chimerism; Waning Immune Function; Primary Immunodeficiency Disease(s); Bone Marrow Failure
- Interventions
- CD34+
- Participants
- 23
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.